Diabetes Type II Clinical Trial
— SUCCEEDOfficial title:
A Pilot Study of the Effects of Diet and Behavioral Interventions on Health in Diabetics
The study is a small pilot, designed to provide data regarding the feasibility and acceptability of conducting such a study on a larger scale. The present study is a randomized controlled clinical trial comparing two mindfulness-based lifestyle modification programs to help people manage diabetes and lose weight, one using on a low-carbohydrate diet (LC) and the other using a moderate-carbohydrate diet promoted by the American Diabetes Association (ADA). Intervention content will include information about nutrition (carbohydrate restriction or American Diabetes Association recommended diet) and emotion regulation and mindful eating strategies.
Status | Completed |
Enrollment | 34 |
Est. completion date | November 2013 |
Est. primary completion date | November 2013 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Diabetes mellitus, Type 2. - HgbA1c > 6.0% at screening. This is to confirm the diabetes diagnosis. - Aged 18 years old and older - BMI 25 and above. Exclusion Criteria: - Condition that will make it difficult for participation. Such as: - cancer - liver failure - unstable coronary artery disease - severe emphysema - bulimia or strong history of bulimia - vegan - Laboratory evidence of organ dysfunction - Abnormal kidney function (serum creatinine) - thyroid stimulating hormone out of normal range - Previous use or new changes in medications that can interfere with the measures used in the study: - current use of insulin and no immediate plans to start or increase diabetic mediations. - more than 3 oral hypoglycemic medications. - use of systemic (oral or IV) corticosteroids in the 6 months prior - severe autoimmune disorders - initiation of psychiatric medications in past 2 months. - Weight loss confounds - Current use of weight loss medications or supplements. - History of or planned weight loss surgery. - Other - Pregnant or planning to get pregnant in the next year, breastfeeding, less than 6 months post-partum. - Unable or unwilling to do home glucose monitoring. |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Osher Center for Integrative Medicine | San Francisco | California |
Lead Sponsor | Collaborator |
---|---|
University of California, San Francisco |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Hemoglobin A1c | We test whether Hemoglobin A1c changes from pre-intervention to 3 months. The key outcome measure will compare the two diet groups, but we will also assess whether statistically significant changes occur within groups from pre-intervention to 3 months. | Change from baseline to 3 months | No |
Secondary | Hemoglobin A1c | We test whether Hemoglobin A1c changes from pre-intervention to 6 months. The key outcome measure will compare the two diet groups, but we will also assess whether statistically significant changes occur within groups from pre-intervention to 6 months. | Change from baseline to 6 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01121315 -
A Retrospective Study of Cardiovascular Events Related to the Use of Glucose Lowering Drug Treatment in Primary Care
|
N/A | |
Completed |
NCT02773095 -
Evaluation of Novartis Access; a Non-communicable Disease (NCD) Access Initiative
|
N/A | |
Completed |
NCT02184455 -
Feasibility Study of DermGEN for Diabetic Foot Ulcer Treatment
|
Phase 1 | |
Recruiting |
NCT02361489 -
Clinical Study to Compare Various Dosing and Titration Guidelines of Insulin Delivered Via V-Go ® in Patients With Type 2 Diabetes Initiating Basal Bolus Therapy in Primary Care Offices
|
Phase 4 | |
Completed |
NCT02326129 -
Novel Biomarker for Development of T2D
|
||
Not yet recruiting |
NCT02074540 -
The Influence of Health Beliefs and Uncertainty on Diabetes Type II Patient Compliance
|
N/A |